NPCE

Neuropace, Inc.

16.19 USD
-0.27 (-1.64%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Neuropace, Inc. stock is up 9.1% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 February’s closed higher than January. 100% of analysts rate it a buy.

About Neuropace, Inc.

NeuroPace, Inc. develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company was incorporated in 1997 and is headquartered in Mountain View, California.